These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma. Jurincic-Winkler CD; von der Kammer H; Beuth J; Scheit KH; Klippel KF Anticancer Res; 1996; 16(4A):2105-10. PubMed ID: 8712751 [TBL] [Abstract][Full Text] [Related]
5. HLA-DR expression by high grade superficial bladder cancer treated with BCG. Prescott S; James K; Busuttil A; Hargreave TB; Chisholm GD; Smyth JF Br J Urol; 1989 Mar; 63(3):264-9. PubMed ID: 2522806 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatment. Saint F; Patard JJ; Groux Muscatelli B; Lefrere Belda MA; Gil Diez de Medina S; Abbou CC; Chopin DK BJU Int; 2001 Oct; 88(6):602-10. PubMed ID: 11678759 [TBL] [Abstract][Full Text] [Related]
7. Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. Prescott S; James K; Hargreave TB; Chisholm GD; Smyth JF J Urol; 1992 Jun; 147(6):1636-42. PubMed ID: 1593713 [TBL] [Abstract][Full Text] [Related]
8. HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections. Ioachim-Velogianni E; Stavropoulos NE; Kitsiou E; Stefanaki S; Agnantis NJ J Pathol; 1994 Nov; 174(3):183-9. PubMed ID: 7823251 [TBL] [Abstract][Full Text] [Related]
9. Local immune responses after intravesical BCG treatment for carcinoma in situ. el-Demiry MI; Smith G; Ritchie AW; James K; Cumming JA; Hargreave TB; Chisholm GD Br J Urol; 1987 Dec; 60(6):543-8. PubMed ID: 3501324 [TBL] [Abstract][Full Text] [Related]
10. Keyhole-limpet haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma. Walsh WG; Tomashefsky P; Olsson CA; deVere White R Urol Res; 1983; 11(6):263-5. PubMed ID: 6659223 [TBL] [Abstract][Full Text] [Related]
11. [The role of lymphocytes and histiocytes as mechanism of action of BCG for bladder cancer]. Kudo S; Suzuki T; Inazumi H Nihon Hinyokika Gakkai Zasshi; 1993 Feb; 84(2):303-12. PubMed ID: 8464184 [TBL] [Abstract][Full Text] [Related]
12. Keyhole limpet hemocyanin for carcinoma in situ of the bladder: a long-term follow-up study. Jurincic-Winkler CD; Metz KA; Beuth J; Klippel KF Eur Urol; 2000; 37 Suppl 3():45-9. PubMed ID: 10828687 [TBL] [Abstract][Full Text] [Related]
13. The CD4+ T-cell response to protein immunization is independent of accompanying IFN-gamma-producing CD8+ T cells. Doyle AG; Ramm L; Kelso A Immunology; 1998 Mar; 93(3):341-9. PubMed ID: 9640244 [TBL] [Abstract][Full Text] [Related]
14. Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder. Jurincic-Winkler C; Metz KA; Beuth J; Sippel J; Klippel KF Anticancer Res; 1995; 15(6B):2771-6. PubMed ID: 8669862 [TBL] [Abstract][Full Text] [Related]
15. Changes in mucosal immune cells of bladder tumor patient after BCG intravesical immunotherapy. Chang SG; Lee SJ; Huh JS; Lee JH Oncol Rep; 2001; 8(2):257-61. PubMed ID: 11182036 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with keyhole limpet hemocyanin: efficacy and safety in the MB-49 intravesical murine bladder tumor model. Swerdlow RD; Ratliff TL; La Regina M; Ritchey JK; Ebert RF J Urol; 1994 Jun; 151(6):1718-22. PubMed ID: 8189604 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subsets in superficial bladder cancer: correlation with biological activity of the tumours. Stavropoulos NE; Ioachim E; Hastazeris K; Goussia A; Agnantis NJ Anticancer Res; 1998; 18(3B):2037-40. PubMed ID: 9677463 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the immunologic mechanism of intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors: distribution and function of immune cells. Chung JY; Lee ES; Lee WJ; Kim HH; Min KJ; Lee C J Korean Med Sci; 1993 Apr; 8(2):135-44. PubMed ID: 8397930 [TBL] [Abstract][Full Text] [Related]
19. Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. Böhle A; Gerdes J; Ulmer AJ; Hofstetter AG; Flad HD J Urol; 1990 Jul; 144(1):53-8. PubMed ID: 2359181 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder. Flamm J; Bucher A Br J Urol; 1991 Jan; 67(1):70-3. PubMed ID: 1993279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]